Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Therapeutic Resistance Models and Treatment Sequencing in Advanced Prostate Cancer.
Cancers (Basel). 2023 Nov 3;15(21):5273. doi: 10.3390/cancers15215273.
Cancers (Basel). 2023.
PMID: 37958444
Free PMC article.
Olaparib-Induced Senescence Is Bypassed through G2-M Checkpoint Override in Olaparib-Resistant Prostate Cancer.
Lombard AP, Armstrong CM, D'Abronzo LS, Ning S, Leslie AR, Sharifi M, Lou W, Evans CP, Dall'Era M, Chen HW, Chen X, Gao AC.
Lombard AP, et al.
Mol Cancer Ther. 2022 Apr 1;21(4):677-685. doi: 10.1158/1535-7163.MCT-21-0604.
Mol Cancer Ther. 2022.
PMID: 35086956
Free PMC article.
Item in Clipboard
IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancer.
Leslie AR, Ning S, Armstrong CM, D'Abronzo LS, Sharifi M, Schaaf ZA, Lou W, Liu C, Evans CP, Lombard AP, Gao AC.
Leslie AR, et al.
iScience. 2024 Jan 20;27(2):108984. doi: 10.1016/j.isci.2024.108984. eCollection 2024 Feb 16.
iScience. 2024.
PMID: 38327800
Free PMC article.
Item in Clipboard
ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signaling.
Liu C, Armstrong CM, Ning S, Yang JC, Lou W, Lombard AP, Zhao J, Wu CY, Yu A, Evans CP, Tepper CG, Li PK, Gao AC.
Liu C, et al.
Oncogene. 2021 Sep;40(35):5379-5392. doi: 10.1038/s41388-021-01914-2. Epub 2021 Jul 16.
Oncogene. 2021.
PMID: 34272475
Free PMC article.
Item in Clipboard
Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment.
Ning S, Liu C, Lou W, Yang JC, Lombard AP, D'Abronzo LS, Batra N, Yu AM, Leslie AR, Sharifi M, Evans CP, Gao AC.
Ning S, et al.
Mol Cancer Ther. 2022 Oct 7;21(10):1594-1607. doi: 10.1158/1535-7163.MCT-22-0216.
Mol Cancer Ther. 2022.
PMID: 35930737
Free PMC article.
Item in Clipboard
Cite
Cite